CLINICAL_TRIALS
trial_result
· 2022-01-26
Clinical Trial Update: Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) [Phase 3]
Summary
Phase 3 trial evaluating immediate postoperative intravesical instillation with either gemcitabine or epirubicin for bladder cancer; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Thessaly | Conditions: Bladder Cancer | Phase 3 | Status: RECRUITING